Agency Forms Undergoing Paperwork Reduction Act Review, 3990-3991 [2023-01160]
Download as PDF
<![CDATA[
3990
Federal Register / Vol. 88, No. 14 / Monday, January 23, 2023 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Individuals and Households ............................
Advance Letter ...............................................
Screener .........................................................
Questionnaire, web ........................................
Questionnaire, phone .....................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–01167 Filed 1–20–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–1283]
Agency Forms Undergoing Paperwork
Reduction Act Review
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Type of respondent
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Monitoring
and Reporting for the Overdose Data to
Action Cooperative Agreement’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on September 7, 2022, to obtain
comments from the public and affected
agencies. CDC received one comment
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
VerDate Sep<11>2014
16:44 Jan 20, 2023
Jkt 259001
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Monitoring and Reporting for the
Overdose Data to Action Cooperative
Agreement (OMB Control No. 0920–
1283, Exp. 01/31/2023)—Revision—
National Center for Injury Prevention
and Control (NCIPC), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
This is a Revision request for the
currently approved Monitoring and
reporting for the Overdose Data to
Action Cooperative Agreement (OMB
Control No. 0920–1283). In 2020, a total
of 91,799 drug overdose deaths occurred
in the United States; the age-adjusted
rate in 2020 was 31% higher than the
rate in 2019. Approximately 75% of
drug overdose deaths in 2020 involved
an opioid, and opioid overdose deaths
in 2020 were 8.5 times the number they
were in 1999. In addition, opioids are
nested in a broadening polysubstance
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
134,933
48,667
26,667
800
Number of
responses per
respondent
1
1
1
1
Average
burden per
response
(in hours)
1/60
5/60
25/60
40/60
crisis, largely driven by deaths coinvolving opioids and stimulants, such
as cocaine and methamphetamine.
While the overdose epidemic worsens
in scope and magnitude, it is also
becoming more complex.
In response to the growing severity of
the opioid overdose epidemic, the U.S.
government declared the opioid
overdose epidemic a Public Health
Emergency (PHE) on October 26, 2017,
joining at least eight states that have
declared the opioid overdose epidemic
a statewide emergency. The opioid
overdose epidemic is one of the U.S.
Department of Health and Human
Services (HHS) top priorities. In 2017,
HHS launched a five-point Opioid
Strategy: (1) Access: Better Prevention,
Treatment, and Recovery Services; (2)
Data: Better Data on the Epidemic; (3)
Pain: Better Pain Management; (4)
Overdoses: Better Targeting of
Overdose-Reversing Drugs; and (5)
Research: Better Research on Pain and
Addiction.
CDC’s overdose surveillance and
prevention efforts include the Overdose
Data to Action (OD2A) cooperative
agreement. The purpose of OD2A is to
support funded jurisdictions in
obtaining high quality, complete, and
timelier data on opioid prescribing and
overdoses involving opioids, stimulants,
and polysubstance use, and to use those
data to inform prevention and response
efforts. The OD2A cooperative
agreement, ending in August 2023, will
be followed by two fundings aimed at
reducing non-fatal and fatal overdoses;
one will be focused on states and the
other on localities. OD2A in States
(OD2A–S) will focus on overdose
surveillance and prevention efforts by
state health departments and
Washington, DC, while OD2A Limiting
Overdose through Collaborative Actions
in Localities (OD2A–LOCAL), will focus
on overdose surveillance and
prevention efforts by city and county
health departments, and territories.
These two cooperative agreements will
allow funded jurisdictions to continue
the work started in OD2A and adapt
their overdose surveillance and
E:\FR\FM\23JAN1.SGM
23JAN1
3991
Federal Register / Vol. 88, No. 14 / Monday, January 23, 2023 / Notices
prevention efforts to the rapidly
changing drug epidemic.
This is a Revision request for the
currently approved Information
Collection Request (ICR) to continue the
collection of information from
jurisdictions (which include states,
Washington, DC, U.S. Territories, cities,
and counties), collect new information
from jurisdictions (which include states
and Washington, DC), and collect new
information from jurisdictions (which
include U.S. Territories, cities, and
counties) funded under the OD2A–
LOCAL. All jurisdictions funded by the
OD2A NOFOs will report activity
progress and capacity and workplan
updates using web-based tools.
Information collected will provide
crucial data for program performance
monitoring, budget tracking, and where
applicable, program success. The
information will also improve
communication between CDC and
funding recipients as well as inform
technical assistance and guidance
documents.
CDC requests OMB approval for an
estimated 1,343 annualized burden
hours. There are no costs to respondents
other than their time to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
OD2A-funded state, territory, county, and city
health departments.
Evaluation and Performance Measuring Plan
Template.
Overdose Prevention Capacity Assessment
Tool.
Annual Performance Report ..........................
OD2A–S Annual Performance Report and
Work Plan.
OD2A–S Evaluation & Performance Measurement Plan Template.
OD2A–S Data Management Plan ..................
OD2A–LOCAL Annual Performance Report
and Work Plan.
OD2A–LOCAL Evaluation & Performance
Measurement Plan Template.
OD2A–LOCAL Data Management Plan ........
OD2A–S-funded state and District of Columbia health departments.
OD2A–LOCAL-funded territory, county, and
city health departments.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–01160 Filed 1–20–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–23–0879; Docket No. CDC–2023–
0003]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Type of respondents
VerDate Sep<11>2014
16:44 Jan 20, 2023
Jkt 259001
comment on a proposed information
collection project titled Information
Collections to Advance State, Tribal,
Local, and Territorial (STLT)
Governmental Agency and System
Performance, Capacity, and Program
Delivery. This collection is used to
assess situational awareness of current
public health emergencies, make
decisions that affect planning, response
and recovery activities of subsequent
emergencies, and fill CDC and HHS gaps
in knowledge of programs and/or STLT
governments that will strengthen
surveillance, epidemiology, and
laboratory science, as well as improve
CDC’s support and technical assistance
to states and communities.
DATES: CDC must receive written
comments on or before March 24, 2023.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2023–
0003 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffery M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
• Instructions: All submissions
received must include the agency name
and Docket Number. CDC will post,
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
66
1
4
66
1
20/60
66
51
1
1
40/60
11
51
1
20/60
51
40
1
1
40/60
9
40
1
20/60
40
1
40/60
without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffery M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
E:\FR\FM\23JAN1.SGM
23JAN1
]]>Agencies
[Federal Register Volume 88, Number 14 (Monday, January 23, 2023)]
[Notices]
[Pages 3990-3991]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01160]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-1283]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Monitoring and Reporting for the Overdose
Data to Action Cooperative Agreement'' to the Office of Management and
Budget (OMB) for review and approval. CDC previously published a
``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on September 7, 2022, to obtain comments from
the public and affected agencies. CDC received one comment related to
the previous notice. This notice serves to allow an additional 30 days
for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Monitoring and Reporting for the Overdose Data to Action
Cooperative Agreement (OMB Control No. 0920-1283, Exp. 01/31/2023)--
Revision--National Center for Injury Prevention and Control (NCIPC),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
This is a Revision request for the currently approved Monitoring
and reporting for the Overdose Data to Action Cooperative Agreement
(OMB Control No. 0920-1283). In 2020, a total of 91,799 drug overdose
deaths occurred in the United States; the age-adjusted rate in 2020 was
31% higher than the rate in 2019. Approximately 75% of drug overdose
deaths in 2020 involved an opioid, and opioid overdose deaths in 2020
were 8.5 times the number they were in 1999. In addition, opioids are
nested in a broadening polysubstance crisis, largely driven by deaths
co-involving opioids and stimulants, such as cocaine and
methamphetamine. While the overdose epidemic worsens in scope and
magnitude, it is also becoming more complex.
In response to the growing severity of the opioid overdose
epidemic, the U.S. government declared the opioid overdose epidemic a
Public Health Emergency (PHE) on October 26, 2017, joining at least
eight states that have declared the opioid overdose epidemic a
statewide emergency. The opioid overdose epidemic is one of the U.S.
Department of Health and Human Services (HHS) top priorities. In 2017,
HHS launched a five-point Opioid Strategy: (1) Access: Better
Prevention, Treatment, and Recovery Services; (2) Data: Better Data on
the Epidemic; (3) Pain: Better Pain Management; (4) Overdoses: Better
Targeting of Overdose-Reversing Drugs; and (5) Research: Better
Research on Pain and Addiction.
CDC's overdose surveillance and prevention efforts include the
Overdose Data to Action (OD2A) cooperative agreement. The purpose of
OD2A is to support funded jurisdictions in obtaining high quality,
complete, and timelier data on opioid prescribing and overdoses
involving opioids, stimulants, and polysubstance use, and to use those
data to inform prevention and response efforts. The OD2A cooperative
agreement, ending in August 2023, will be followed by two fundings
aimed at reducing non-fatal and fatal overdoses; one will be focused on
states and the other on localities. OD2A in States (OD2A-S) will focus
on overdose surveillance and prevention efforts by state health
departments and Washington, DC, while OD2A Limiting Overdose through
Collaborative Actions in Localities (OD2A-LOCAL), will focus on
overdose surveillance and prevention efforts by city and county health
departments, and territories. These two cooperative agreements will
allow funded jurisdictions to continue the work started in OD2A and
adapt their overdose surveillance and
[[Page 3991]]
prevention efforts to the rapidly changing drug epidemic.
This is a Revision request for the currently approved Information
Collection Request (ICR) to continue the collection of information from
jurisdictions (which include states, Washington, DC, U.S. Territories,
cities, and counties), collect new information from jurisdictions
(which include states and Washington, DC), and collect new information
from jurisdictions (which include U.S. Territories, cities, and
counties) funded under the OD2A-LOCAL. All jurisdictions funded by the
OD2A NOFOs will report activity progress and capacity and workplan
updates using web-based tools.
Information collected will provide crucial data for program
performance monitoring, budget tracking, and where applicable, program
success. The information will also improve communication between CDC
and funding recipients as well as inform technical assistance and
guidance documents.
CDC requests OMB approval for an estimated 1,343 annualized burden
hours. There are no costs to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
OD2A-funded state, territory, county, Evaluation and 66 1 4
and city health departments. Performance Measuring
Plan Template.
Overdose Prevention 66 1 20/60
Capacity Assessment
Tool.
Annual Performance 66 1 40/60
Report.
OD2A-S-funded state and District of OD2A-S Annual 51 1 11
Columbia health departments. Performance Report and
Work Plan.
OD2A-S Evaluation & 51 1 20/60
Performance Measurement
Plan Template.
OD2A-S Data Management 51 1 40/60
Plan.
OD2A-LOCAL-funded territory, county, OD2A-LOCAL Annual 40 1 9
and city health departments. Performance Report and
Work Plan.
OD2A-LOCAL Evaluation & 40 1 20/60
Performance Measurement
Plan Template.
OD2A-LOCAL Data 40 1 40/60
Management Plan.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2023-01160 Filed 1-20-23; 8:45 am]
BILLING CODE 4163-18-P
